SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

6 hedge funds and large institutions have $965K invested in Seelos Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$89K

Top Sellers

1
-$796K
2
-$731K
3
-$71K
4
Citadel Advisors
Citadel Advisors
Florida
-$63K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$42.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$564K
2
$127K
3
$89K
4
$41K
5
$39K
6
$33K
7
$15K
8
$14.2K
9
$10K
10
$8K
11
$8K
12
$6K
13
$4K
14
$4K
15
$1K
16
$1K
17
$1K
18
–
19
–
20
–
21
–
22
–
23
–